chrisvoncsefalvay/vaers-outcomes huggingface dataset:
MMR and Fluzone HD were administered. After administration the patient asked his wife to get him some water. I offered to get him some water. I left to ask a technician to help find me find water for the patient. Upon returning with water and nearing the immunization room, the wife opened the door and asked for someone to call 911. I ran into the room. The patient was coming to. Wife stated his eyes rolled back and his head tilted back. She thought he had a seizure as he had a history of hemorrhagic stroke. He was alert and asked what happened. He remained in his chair during the event. It did not appear that patient had any loss of bladder control.  He did have some water and placed a wet paper towel on his forehead. I took his blood pressure (123/86) and pulse (60). He was clammy and wife stated he looked ashen. Paramedics arrived and took over monitoring his blood pressure and pulse. His pulse was was lower in the 30-40s. He told paramedics he was feeling nauseous. They encouraged patient to be transported to the hospital to be checked out. Wife stopped back in later the same evening and stated he was doing fine and had been released. They were told it was a vagal response.
muscle soreness; This is a spontaneous report from a contactable physician (patient). A patient of an unspecified age (reported as 35, unit unknown) and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration from 15Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that after he got the shot (Dec2020), he had experienced "just a little muscle soreness". The outcome of event was unknown.  Follow-up attempts are completed. The following information on the batch number has been requested.
Black crescent in peripheral of left eye after shot.  Should be noted patient has history of headaches and migraines
lymph node in the arm pit where got my shot got sore; lymph node in the arm pit where got my shot got swollen; pain and soreness moved to my right breast; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old adult female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6208), via an unspecified route of administration in the right arm on 17Mar2021 at 12:00 (at the age of 21-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history and no allergies to medications, food, or other products. Concomitant medications were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 19Mar2021 at 12:00, the patient experienced sore and swollen lymph node in the arm pit where she got her shot after days receiving the vaccine. The patient also reported that the pain and soreness moved to her right breast after the lymph node pain subsided. The patient underwent lab tests and procedures post vaccination, which included COVID-19 virus test on 22Mar2021, and the result was found to be negative. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events lymph node pain and lymphadenopathy was recovering and the clinical outcome of the event breast pain was unknown.   No follow-up attempts are needed. No further information is expected. .
I was feeling tingling down my arm to my hand, it affected my ring finger and pinky finger, in my right arm. Went to see shoulder specialist and ordered an EMG and prescribed gabapentin.
(05/06/2021 1st dose of Jansen administered/ No reaction) Pt. states that after receiving the 2nd dose of Jansen 12/22/2021, started experiencing symptoms 03:30am 12/23/2021 of extreme muscle spasms and pain in the right side of the back. Vomiting and right side of the hip experienced numbness. Emergency Room visit 12/23/2021 02:00pm, X-Ray preformed of right lower back (Lumbar) and Urine Test(Culture)/Blood Panel/LFT (Hepatic Panel). Vomiting noted as "Due to the reaction of Vaccine administered 12/22/2021". Pain subsided within 2 weeks with numbness of the right hip/lower thigh-back continuing. Primary recommendations of PT after care. 05/06/2021 1st dose of Jansen administered.
Severe headache, joint pain, muscle ache. Vomiting regularly for 8 hours. Severe dehydration. Did not seek medical care. Symptoms subsided in the late evening and were clear by the next day.
Patient presents for immunization visit. Prior to calling pt. and mother into Exam Room, I reviewed Vaccine Forecaster. I reviewed the vaccine forecaster for a second time with RN. We agreed patient was due Hep A vaccine. I called the patient into exam room and asked the mother the reason for today's visit. Mother reports patient is due for a vaccine. She agreed she was due the Hep A vaccine. Hep A vaccine was administered. When entering in the immunization on EHR record, the immunization chart tab indicated after today's dose there has been three doses of Hep A vaccine given. The second dose on 05/23/2022 did not appear on vaccine forecaster or the Certificate of Immunization. After noting the third vaccine, mother was asked about the second Hep A vaccine. Her mother does not recall coming to this health department last year for any vaccine. After the third Hep A vaccine was administered today, the vaccine forecaster indicates the Hep A series is completed and shows the Hep A was given on 10/18/2021 and  05/30/2023. Second Hep A dose, 05/23/2022, is missing.
Sandpaper like rash over entire body for the following 3 days. Mother did not bring child for a provider to exam this rash.
sore arm; elevated temperature; chills; late 2nd dose; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 54-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain in extremity (1st dose received on 9th January 2020, please refer the case US2020144317.).   On 15th July 2020, the patient received the 2nd dose of Shingrix. On 15th July 2020, less than a day after receiving Shingrix, the patient experienced pain in arm, body temperature increased, chills and drug dose administration interval too long. Rechallenge with Shingrix was positive. On 17th July 2020, the outcome of the body temperature increased and chills were recovered/resolved. On 19th July 2020, the outcome of the pain in arm was recovered/resolved. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the pain in arm, body temperature increased and chills to be related to Shingrix.  Additional case details were reported as follows: The patient experienced the events after receiving her second doses of Shingrix. On 15th July 2020, the patient received the 2nd dose of Shingrix late, which led to lengthening of the vaccination schedule. The reporter consent to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020144317:same reporter
Metalic taste and smell- still have metallic taste and smell; Metalic smell; This is a spontaneous report from a contactable other healthcare professional. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the left arm on 03Feb2021(at the age of 42-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the left arm on 26Feb2021 at 07:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included Hepatitis B and COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medications included entecavir (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 18Feb2021, the patient experienced metallic taste and smell. The patient still had metallic taste and smell at the time of reporting as on 02April2021. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event metallic taste and smell was not recovered at the time of reporting.  No follow-up attempts are needed. No further information is expected.
PATIENT CAME IN TODAY 8/31/16 IN THE AM AND HAD A SMALL REDNESS AT LOCATION OF VACCINATION. I ADVISED PATIENT TO TAKE BENADRYL FOR REACTION AND TO MARK PERIMETER OF REDNESS TO SEE IF IT PROGRESSIVELY GETS WORSE OR BETTER. PATIENT CALLED ME BACK IN THE EVENING AT 8:30 PM STATING THAT IT HAD "TRIPLED IN SIZE". I ADVISED PATIENT TO SEEK IMMEDIATE MEDICAL ATTENTION TO TREAT REACTION.
I started having pain in bilateral shoulders, and hips at the end of September 2021. It was moderate to severe pain. I was waking in the middle of the night because it hurt so bad and ached. My arms were weak and I had trouble shutting the car door or opening the shower door. My ROM was limited as well.
Started with calf pain then progressed to widespread pain Fibromyalgia diagnosis in 2014
On 9/18/14 at 16:00, 59 year old arrived our clinic for immigration immunizations. Patient was inadvertently given Tdap instead of Td. Pt received Tdap vaccine on 04-30-14, so just needed Td at this time.
24 hrs after immunizations pt developed migraine type headache (3-4 PM) then 6 P fever, chills, body aches. At 9 PM fever increased 101.8 F - took TYLENOL and went to sleep. Also had joint pain of knees, elbows and lower back pain. All resolved within 48 hrs. No residual effects.
CHIEF COMPLAINT:   pt reports a productive cough starting last night and "i have a big bump on my chest", points to right side chest. feels SOB. hx of COPD and CHF.   HISTORY OF PRESENT ILLNESS:     Patient is a 75-year-old male who presents emergency department with complaints of cough and abdominal pain.  He states last night he started to develop a cough that was productive of thick sputum.  He denies shortness of breath, chest pain.  He denies any fever, chills.  He also noticed last night that he was starting to experience of abdominal pain.  He states that he felt a lump in his abdomen that is tender to touch.  He denies nausea, vomiting, diarrhea.  He states he did have colon surgery about 20 years ago he does not recall his surgeon.  He has not had any issues with his bowels since his surgery.  He admits to history of diabetes, hypertension.
Symptoms started with feeling slightly faint with legs feeling weak from knees down, followed by 3 minutes of tachycardia at 130-140 BPM.  Resolved without intervention;   At (12/23/2020 app 23:40PM) developed periods of hot and cold, muscle aches and restlessness
This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a adult female patient who received SHINGRIX for prophylaxis. On 20th July 2018, the patient received SHINGRIX (intramuscular). On 20th July 2018, less than a day after receiving SHINGRIX, the patient experienced injection site erythema and injection site warmth. On 26th July 2018, the outcome of the injection site erythema and injection site warmth were recovered/resolved. It was unknown if the reporter considered the injection site erythema and injection site warmth to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient received SHINGRIX on left arm. The patient experienced injection site hot to touch. Limited information was provided by the pharmacist.
side effects after receiving the Moderna covid-19 vaccine/"knocked her out."; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effects after receiving the Moderna covid-19 vaccine/"knocked her out.") in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Liver transplant (Patient had liver transplant last October.) in October 2020. Concurrent medical conditions included Diabetic.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects after receiving the Moderna covid-19 vaccine/"knocked her out."). At the time of the report, VACCINATION COMPLICATION (side effects after receiving the Moderna covid-19 vaccine/"knocked her out.") had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: low (Low) Low response.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment medications were not provided by the reporter
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 59-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 13Aug2021 at 16:30 as dose 1, single (Lot number: FC3180), in right arm and on 03Sep2021 at 17:00 as dose 2, single (Lot number: FC3182) at the age of 58 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Immune disorder" (unspecified if ongoing); "hyperlipidemia" (unspecified if ongoing); "gerd" (unspecified if ongoing). Concomitant medication(s) included: METOPROLOL, start date: 01Nov2021; BUSPIRONE, start date: 01Nov2021; ROSUVASTATIN, start date: 01Sep2019; ESOMEPRAZOLE, start date: 01Sep2021. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of vaccination failure, covid-19 with anti viral started on 27Jul2022 and stopped on 01Aug2022.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events and the suspect drug BNT162B2.
About 7 hours after receiving the vaccine, I became very ill with a fever, chills, body aches, and severe arm pain.
patient denied having previous vaccine however it was discovered when reporting 09/10/2021 vaccine that the patient had received a previous janssen vaccine on 03/19/2021 at another facility
Severe episode of gout: swelling, redness and pain in great toe. Started mildly for a few days, went away, and came back intensely on May 16. Lasted 1 week. I have never had anything like this before.
Patient's age has not been approved for Moderna yet. No adverse reactions reported 3 hours after vaccination, right before reporting this.
Very little side effects; This spontaneous case was reported by a patient family member or friend and describes the occurrence of VACCINATION COMPLICATION (Very little side effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Very little side effects). At the time of the report, VACCINATION COMPLICATION (Very little side effects) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment information was not provided.
pain in his stomach; he threw up food; very dizzy; abdominal started to hurt very badly right side; spleen was inflammed; arm hurting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurting), ABDOMINAL PAIN (abdominal started to hurt very badly right side), SPLENITIS (spleen was inflammed), ABDOMINAL PAIN UPPER (pain in his stomach) and DIZZINESS (very dizzy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Feb-2022 at 5:30 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (arm hurting). On 03-Feb-2022, the patient experienced ABDOMINAL PAIN (abdominal started to hurt very badly right side), SPLENITIS (spleen was inflammed) and DIZZINESS (very dizzy). On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (pain in his stomach) and VOMITING (he threw up food). At the time of the report, PAIN IN EXTREMITY (arm hurting), ABDOMINAL PAIN (abdominal started to hurt very badly right side), SPLENITIS (spleen was inflammed), ABDOMINAL PAIN UPPER (pain in his stomach), DIZZINESS (very dizzy) and VOMITING (he threw up food) outcome was unknown.     No concomitant medications were provided by the reporter. On 3-Feb-2022, patient went to work and was very dizzy, so he came home and then his abdominal started to hurt very badly on his right side he ended up having to go to the hospital and the doctor said his spleen was inflamed and just sent him home to rest. Patient just find this to be all apart because of this vaccine. No treatment medications were provided by the reporter.
Information has been received from a female nurse of an unknown age, reporting on herself. In 1997, "15 years ago", the patient was vaccinated with a dose of MMR II, dose, route and frequency were not provided. In 1997, the patient experienced a bad rash. No treatment was given for the event. The patient did not seek medical attention. At the time of the report, the patient had recovered from the bad rash (date not reported). Additional information is not expected.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fainting / Unresponsive-Medium, Additional Details: Pale, bradycardic, slow to respond.  911 was called and responded.  Patient walked out on his own and left with family
Information has been received from a health professional concerning a 5 year old female who "4 years ago" (2004) was vaccinated with varicella virus vaccine live (Oka/Merck). It was indicated that 1 year ago (2007), the patient developed shingles and recovered. A product quality complaint was not reported. Additional information has been requested.
PATIENT DESCRIBED A RASH ON THE WHOLE LEFT SIDE OF THE BODY AND SWEELING (ROUGHLY THE SIZE OF AN EGG) AROUND 3 INCHES BELOW THE INJECTION SITE)
Arm was hurting; A spontaneous report was received from a consumer concerning her husband a 73-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced arm was hurting/ limb discomfort.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 23 Jan 2021, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (batch: 0280L20A) via unknown route in the right arm for prophylaxis of COVID-19 infection.  On 23 Jan 2021, the patient's arm hurts. Treatment information was not provided.   Action taken with mRNA-1273 in response to the event was not reported.  The outcome of event, arm was hurting was unknown.; Sender's Comments:  MOD21-035070:
I originally was fatigued and had some headaches. That dissapated pretty quickly. That went away within a couple days of my vaccine. I started feeling better. I would occasionally get headaches. I was still able to work and everything. Then I got a concussion. It made my headaches much worse. I do not consider that to be an adverse effect. This past Friday, I felt like my eye had some grit in it. My right eye felt like I had something in it. It started to tear up and it was getting really red. Saturday, it got quite a bit worse. I was tearing quite a bit. Sunday, it was oozing and extremely red. Some of the tears had a pink tint to them. Monday, I had a Telehealth appointment and took a picture of my eye to send to the doctor. He prescribed an optomic solution. I started taking that the same day. I started feeling better. I take 2 drops every four hours that I am awake. It is still pink, but definitely feeling better. A couple of weeks ago, I did see a doctor, but it was just a physical.
Fever; hair loss; trouble walking; lack of energy; high heart rate; This is a spontaneous report from a contactable consumer (patient), based on information received by Pfizer from Bristol-Myers Squibb (manufacturer control number US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-042611). This case was split from master case AER #2021577283 to capture a female patient taking BNT162B2 and experienced fever, hair loss, trouble walking, lack of energy and a high heart rate.  A 70-years-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on an unspecified date as unknown, single (received her COVID vaccine since being diagnosed) for COVID-19 immunisation. Medical history included ongoing COVID-19 (does not know where she got COVID) and hospitalisation (for COVID and while in the hospital started on ELIQUIS for blood clots that where found in her lungs). Concomitant medication(s) included apixaban (ELIQUIS) oral taken for pulmonary embolism twice a day (batch no. 1796051); ascorbic acid; colecalciferol and zinc. On an unspecified date, the patient experienced fever, hair loss, trouble walking, lack of energy and high heart rate. The patient underwent lab tests and procedures which included computerised tomogram: lungs look much better, had scaring on lungs from COVID but did not see any blood clots on 29Apr2021 and heart rate: high on an unspecified date. The outcome of the events were unknown.
10 Seconds after receiving the Vaccine the patient fell over in his chair and on how way to the ground I caught him and laid him down on his back. During this time the patient's eyes rolled into the back of his head and had small tremors occuring throughout his body. This lasted approxiamtely 10 seconds before the patient regained consciousness. The patient has had no history of seizures or any issues with the first dose. The patient had reported that they had not ate anything all day and felt like their glucose was low. After observing the patient for 30 minutes after the incident they reporting feeling okay and just that they probably needed to eat something. A follow up call with the patients mother was completed 2 hours later and the patient was feeling better and eating. They were informed to call back with any issues.